Engineered polymer conjugation for targeted, stable, and tunable biomolecules.
Synthetic polymer conjugation attaches engineered polymers to biomolecules or therapeutic payloads to improve stability, solubility, circulation time, pharmacokinetics, and controlled delivery.
Synthetic polymers provide control over molecular weight, reactive handles, polymer architecture, and degradation behavior. This allows conjugates to be customized for drug delivery, biologics stabilization, targeted delivery, diagnostics, and research applications.
Polymer bioconjugation can be applied to multiple biomolecules and therapeutic agents. Select a category below to explore detailed conjugation strategies and applications.
Improve solubility, stability, biodistribution, and controlled release of therapeutic payloads.
Explore more →
Modify ligands, probes, and small bioactive compounds for improved delivery and handling.
Includes IgG, IgM, fragments, and nanobodies for targeting and half-life extension.
Enhance stability and delivery of DNA, RNA, antisense oligos, and siRNA constructs.
Improve proteolytic stability, solubility, and bioavailability of peptide therapeutics.
Reduce aggregation, improve stability, and extend activity of enzymes and biologics.
The table below summarizes representative synthetic polymers used in polymer bioconjugation, including PEGylation systems, biodegradable polymers, dendrimers, and stimuli-responsive polymers. These systems are selected based on molecular weight, architecture, functional groups, and intended application.
PEG systems are commonly used for PEGylation for drug delivery, while polymer architecture and reactive handles can be tuned for oligonucleotide–polymer conjugation, peptide–polymer conjugation, and antibody–polymer conjugation.
Additional custom synthetic polymers, MW ranges, architectures, and functional groups can be designed and synthesized based on project requirements.
Polymer molecular weight, chain length, branching, and dendritic structure influence solubility, steric shielding, clearance, and binding activity.
Site selection affects activity and reproducibility. Common targets include amines, thiols, carboxyls, aldehydes, azides, alkynes, and engineered handles.
Stable, cleavable, biodegradable, or stimuli-responsive linkers are selected based on whether permanent modification or controlled release is preferred.
Polymer loading and conjugation density must be controlled to balance activity, solubility, shielding, and manufacturability.
Proteins, antibodies, oligos, and peptides may require mild aqueous conditions, orthogonal chemistry, and tailored purification.
Analytical strategy may include HPLC/UPLC, LC-MS, SEC, SDS-PAGE, UV/Vis, conjugation ratio, free payload, and stability testing.
Improve solubility, release profile, biodistribution, and stability of therapeutic payloads.
Extend half-life, reduce aggregation, and improve formulation behavior for proteins and enzymes.
Modify antibodies and fragments for stability, shielding, delivery, or multivalent presentation.
Use polymer conjugation to tune stability, clearance, and delivery of siRNA, ASO, DNA, and RNA systems.
Attach probes, dyes, reporters, or affinity groups to synthetic polymer scaffolds.
Enable pH-, temperature-, redox-, or enzyme-responsive release and targeting strategies.
Explore related synthetic polymer conjugation services for PEGylation, oligonucleotide delivery, peptide modification, antibody systems, and cross-platform bioconjugation.
Synthetic polymer conjugation attaches engineered polymers such as PEG, PLGA, PNIPAM, or dendrimers to biomolecules or therapeutic payloads to improve stability, solubility, pharmacokinetics, and delivery.
Common targets include oligonucleotides, peptides, antibodies and fragments, proteins, drugs, and small molecules.
Yes. PEGylation is one of the most common synthetic polymer conjugation strategies and uses polyethylene glycol to improve solubility, stability, and circulation time.
Yes. PLGA, PLA, and related degradable polymers are used when controlled degradation, release, or clearance is desired.
For the fastest review, send your target molecule, preferred polymer or polymer class, available functional groups, desired conjugation ratio, quantity, purity target, and intended application.
These references cover PEGylation, polymer therapeutics, dendrimers, and delivery systems, along with key advances in glycoconjugation and lipid-based delivery, reflecting the broader landscape of bioconjugation technologies.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.